AIM ImmunoTech, Inc. (AIM)
0.2297
0.00 (0.00%)
USD |
NYAM |
Sep 08, 16:00
0.2334
0.00 (0.00%)
Pre-Market: 08:26
AIM ImmunoTech Price to Book Value : 0.8599 for Sept. 8, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 0.8599 |
| September 04, 2026 | 0.852 |
| September 03, 2026 | 0.8749 |
| September 02, 2026 | 0.8782 |
| September 01, 2026 | 0.8835 |
| August 31, 2026 | 0.846 |
| August 28, 2026 | 0.9673 |
| August 27, 2026 | 0.9359 |
| August 26, 2026 | 0.9359 |
| August 25, 2026 | 0.9509 |
| August 24, 2026 | 0.9509 |
| August 21, 2026 | 0.9673 |
| August 20, 2026 | 0.9475 |
| August 19, 2026 | 0.8917 |
| August 18, 2026 | 0.8756 |
| August 17, 2026 | 0.9097 |
| August 14, 2026 | 0.8232 |
| August 13, 2026 | 0.9681 |
| August 12, 2026 | 0.9621 |
| August 11, 2026 | 0.9535 |
| August 10, 2026 | 0.9845 |
| August 07, 2026 | 1.068 |
| August 06, 2026 | 1.014 |
| August 05, 2026 | 1.062 |
| August 04, 2026 | 0.9845 |
| Date | Value |
|---|---|
| August 03, 2026 | 0.9883 |
| July 31, 2026 | 0.9494 |
| July 30, 2026 | 0.8797 |
| July 29, 2026 | 0.8984 |
| July 28, 2026 | 0.8835 |
| July 27, 2026 | 0.9359 |
| July 24, 2026 | 0.9321 |
| July 23, 2026 | 0.9359 |
| July 22, 2026 | 0.9486 |
| July 21, 2026 | 0.9321 |
| July 20, 2026 | 0.9359 |
| July 17, 2026 | 0.9621 |
| July 16, 2026 | 1.022 |
| July 15, 2026 | 0.9658 |
| July 14, 2026 | 0.9958 |
| July 13, 2026 | 0.9958 |
| July 10, 2026 | 1.059 |
| July 09, 2026 | 1.085 |
| July 08, 2026 | 1.086 |
| July 07, 2026 | 1.144 |
| July 06, 2026 | 1.112 |
| July 02, 2026 | 1.048 |
| July 01, 2026 | 1.108 |
| June 30, 2026 | 1.063 |
| June 29, 2026 | 1.146 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.633 |
| Alnylam Pharmaceuticals, Inc. | 25.69 |
| Anika Therapeutics, Inc. | 2.051 |
| Savara, Inc. | 7.907 |
| Vericel Corp. | 5.404 |
Price to Book Value Related Metrics
| PS Ratio | 16.10 |
| Price | 0.2297 |
| Earnings Yield | -1.67K% |
| Market Cap | 6.659M |